Bristol-Myers Squibb was founded in 1858 and has grown ... Around the same time, the prototype of the Squibb logo was designed. The logo represented product uniformity, purity, efficacy and ...

EpiVax, Inc., a leader in preclinical immunogenicity assessment for biologic therapeutics and vaccines, is pleased to announce the appointment ...

Bristol-Myers Squibb's financial position improved, it raised both its EPS guidance and revenue expectations, and Opdivo's ...

Plenge currently works at PhRMA Foundation, as Director and Bristol Myers Squibb Co., as Chief Research Officer, Head-Research & EVP from 2019. Dr. Plenge also formerly worked at Translate Bio, Inc., ...

Combined with the last dividend raise by +3.3% in December 2024, building upon the 10Y growth profile at +5.27%, we believe ...

The stock's fall snapped a four-day winning streak.

PRINCETON, N.J., May 06, 2025--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced the appointment of Cari Gallman as Executive Vice President, General Counsel and Chief Policy ...

Princeton-based pharma Bristol Myers Squibb is planning another round of layoffs in New Jersey as part of a broader restructuring plan. In a filing with the state Department of Labor & Workforce ...

Bristol Myers Squibb Co. (Symbol: BMY) presently has a stellar rank, in the top 10% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further ...

Bristol Myers Squibb (BMS) plans to invest $40bn in the US over the next five years to bolster its research and manufacturing capabilities, reported Reuters. BMS CEO Christopher Boerner first ...

Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the Bernstein 41 st Annual Strategic Decisions Conference on Wednesday, May 28, 2025. The company will take part ...